|
Gene
|
SNP ID
|
Model
|
Genotype
|
Control
|
Nasopharyngeal carcinoma
|
Thyroid carcinoma
|
|---|
|
Case
|
OR (95% CI)
|
p
|
Case
|
OR (95% CI)
|
p
|
|---|
|
IL-1B
|
rs1143643
|
Allele
|
C
|
564
|
87
|
1
| |
371
|
1
| |
| |
T
|
512
|
72
|
1.02 (0.72–1.43)
|
0.924
|
425
|
1.26 (1.05–1.52)
|
0.013*
|
|
Genotype
|
CC
|
146
|
20
|
1
| |
82
|
1
| |
| |
CT
|
272
|
38
|
1.03 (0.51–2.07)
|
0.946
|
207
|
1.61 (1.1–2.34)
|
0.014*
|
| |
TT
|
120
|
17
|
1.06 (0.59–1.91)
|
0.841
|
109
|
1.34 (0.97–1.86)
|
0.080
|
|
Dominant
|
CC
|
146
|
20
|
1
| |
82
|
1
| |
| |
CT-TT
|
392
|
55
|
1.05 (0.60–1.83)
|
0.863
|
316
|
1.42 (1.04–1.94)
|
0.027*
|
|
Recessive
|
CC-CT
|
418
|
58
|
1
| |
289
|
1
| |
| |
TT
|
120
|
17
|
0.99 (0.55–1.77)
|
0.961
|
109
|
1.31 (0.97–1.78)
|
0.078
|
|
Log-additive
| | | |
1.01 (0.72–1.44)
|
0.936
| |
1.27 (1.05–1.53)
|
0.015*
|
- SNP single nucleotide polymorphism, OR odds ratio, 95% CI 95% confidence interval
-
p values were calculated by logistic regression analysis with adjustments for age and gender
- *p < 0.05 respects the data is statistically significant
